Almstead Neil Gregory bought PTCT
June 25, 2026 · Form 4 insider transaction
Almstead Neil Gregory bought 19,859 shares of PTC Therapeutics, Inc. at $38.10 per share, a transaction worth $756.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
19,859
Price
$38.10
Total value
$756.6K
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 25, 2026
Filing dateJune 26, 2026
Shares owned after79,996
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.